IgA MAb blocks SARS-CoV-2 Spike-ACE2 interaction providing mucosal immunity
M. Ejemel, Q. Li, S. Hou, Z. A. Schiller, A. L. Wallace, A. Amcheslavsky, N. Kurt Yilmaz, J. R. Toomey, R. Schneider, B. J. Close, D.-Y. Chen, H. L. Conway, M. Saeed, L. A. Cavacini, M. S. Klempner, , Y. Wang
This study identifies an IgA monoclonal antibody that blocks SARS-CoV-2 Spike-ACE2 interaction and provides mucosal immunity.
bioRxiv · May 15, 2020 · PreprintMicrobiology